To investigate the possible role of IL‐8 in ovarian cancer, we exogenously activated or inhibited IL‐8 effect in ovarian cancer cells using IL‐8 or Reparixin (inhibitor of both IL‐8 receptors CXCR1, CXCR2). This evidence concerns the gene CXCR2 and ovarian carcinoma.